Purchase Order 75N95019P00462
Award Date 7/23/19
Potential Completion Date 9/30/19
Potential Value $25K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Research Triangle Park, NC 27709, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $249,500 firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse to Chemogenics Biopharma, LLC, a small business. The contract is for synthesis and bioanalytical analysis support services related to the therapeutic areas of the microbiome, neurodegeneration, and addiction. The services will augment existing medicinal chemistry campaigns within the National Center for Advancing Translational...
- The National Institute on Drug Abuse awarded a $101,000 firm fixed-price purchase order to Chemogenics Biopharma, LLC on September 16, 2025, for synthesis and bioanalytical analysis services supporting the National Center for Advancing Translational Sciences (NCATS) Early Translational Branch Chemistry Program. The contract, which extends through July 15, 2026, is performable in Durham, North Carolina. This procurement does not utilize a small business set-aside designation. The work involves...
- <p>The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a firm-fixed-price purchase order to Chemdiv, Inc. to provide 10,000 proprietary chemical compounds at 8 micromolar each. The total potential value of the award is $128,000.00. The award was not set aside for any specific business type. The contract has a completion date of September 4, 2017.</p>
- The federal contract award HHSN271201500037A, valued at $498,000.00, was issued by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The contract was awarded to Chemdiv, Inc., a for-profit organization based in San Diego, California, to provide small molecule compounds to support the National Center for Advancing Translational Sciences (NCATS) Pharmacologically Active Chemical Toolbox...
- The National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) awarded a $240,000.00 firm fixed-price purchase order to Chemogenics Biopharma, LLC, a for-profit limited liability company, for custom synthesis and bioanalytical services to support NCATS' internal projects focused on developing small molecule inhibitors of physiological small molecule methyltransferases. The 12-month contract is not set aside and is awarded under FAR Part 13 simplified...
- This is a $235,092.20 firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse to MedChemExpress LLC, a New Jersey-based provider of biochemicals and other life science research materials. The contract is for the delivery of a custom chemical library of 84 items to the National Center for Advancing Translational Sciences (NCATS) to support its COVID-19 research. No set-aside designation was used. As a...
- This is a $90,800.00 firm-fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, to Chemaxon LLC, a foreign-owned for-profit limited liability company. The contract, which has a completion date of September 29, 2023, is for the provision of ChemAxon software licenses, including JChem Oracle Cartridge, Marvin JS, JChem Base, and Instant JChem Enterprise. These specialized...
- <p>This is a $18,963.00 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to NINDS PHARMAC LLC for medicinal chemistry consulting services. The contract has a Total Small Business set-aside designation. The contract was awarded on January 12, 2017 and has an ultimate completion date of January 12, 2022. The place of performance is Bethesda, Maryland.</p>
- <p>The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse awarded a $104,870.00 firm fixed price purchase order contract to Life Chemicals Inc., a for-profit organization, for services to be performed in Canada. The contract was not set aside for any special designation. The award was made on September 7, 2017, with a completion date of November 1, 2017.</p>
- This is a $78,489 firm fixed-price purchase order award to Government Scientific Source Inc. by the National Institute on Drug Abuse (NIDA) for the 10X Genomics Chromium Single Cell Multiome ATAC + Gene Expression Reaction Kits and associated maintenance and service plan. The award was made on a sole-source, non-competitive basis under simplified acquisition procedures. The kits will be used by NIDA's Chittiboina Lab to study the pathology and cell interactions within tumors related to Cushing's...